| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |